Protein FOG is a moderate inducer of MIG/CXCL9, and group G streptococci are more tolerant than group A streptococci to this chemokine's antibacterial effect

Microbiology

Volumn 153, Issue 11, 2007, Pages 3800-3808

  Linge, Helena M ^a   Sastalla, Inka ^b   Nitsche Schmitz, D Patric ^b   Egesten, Arne ^a   Frick, Inga Maria ^a  

^a LUND UNIVERSITY   (Sweden)

^b HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; CXCL9 CHEMOKINE; LEUKOCYTE ELASTASE; PROTEIN FOG; UNCLASSIFIED DRUG;

ARTICLE; BACTERICIDAL ACTIVITY; COMMENSAL; CONTROLLED STUDY; EPITHELIUM CELL; HOST SUSCEPTIBILITY; HUMAN; HUMAN CELL; INNATE IMMUNITY; IONIC STRENGTH; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SECRETION; SENSITIVITY ANALYSIS; STREPTOCOCCUS GROUP A; STREPTOCOCCUS GROUP G;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; CELL LINE; CHEMOKINE CXCL9; EPITHELIAL CELLS; FIBRINOGEN; HUMANS; MONOCYTES; STREPTOCOCCUS; STREPTOCOCCUS PYOGENES;

BACTERIA (MICROORGANISMS); STREPTOCOCCUS DYSGALACTIAE SUBSP. EQUISIMILIS; STREPTOCOCCUS PYOGENES; STREPTOCOCCUS SP. 'GROUP A'; STREPTOCOCCUS SP. 'GROUP G';

EID: 36448955371     PISSN: 13500872     EISSN: None     Source Type: Journal    
DOI: 10.1099/mic.0.2007/009647-0     Document Type: Article

References (39)

1. Åkesson, P., Schmidt, K. H., Cooney, J. & Björck, L. (1994). M1 protein and protein H: IgGFc- and albumin-binding streptococcal surface proteins encoded by adjacent genes. Biochem J 300, 877-886.
2. Auckenthaler, R., Hermans, P. E. & Washington, J. A., II (1983). Group G streptococcal bacteremia: clinical study and review of the literature. Rev Infect Dis 5, 196-204.
3. Bals, R., Wang, X., Wu, Z., Freeman, T., Bafna, V., Zasloff, M. & Wilson, J. M. (1998). Human beta-defensin 2 is a salt-sensitive peptide antibiotic expressed in human lung. J Clin Invest 102, 874-880.
4. Berge, A. & Björck, L. (1995). Streptococcal cysteine proteinase releases biologically active fragments of streptococcal surface proteins. J Biol Chem 270, 9862-9867.
5. Björck, L. & Kronvall, G. (1984). Purification and some properties of streptococcal protein G, a novel IgG-binding reagent. J Immunol 133, 969-974.
6. Björck L., Kastern, W., Lindahl, G. & Widebäck, K. (1987). Streptococcal protein G, expressed by streptococci or by Escherichia coli, has separate binding sites for human albumin and IgG. Mol Immunol 24, 1113-1122.
7. Bowler, P. G., Duerden, B. I. & Armstrong, D. G. (2001). Wound microbiology and associated approaches to wound management. Clin Microbiol Rev 14, 244-269.
8. Cole, A. M., Ganz, T., Liese, A. M., Burdick, M. D., Liu, L. & Strieter, R. M. (2001). Cutting edge: IFN-inducible ELR-CXC chemokines display defensin-like antimicrobial activity. J Immunol 167, 623-627.
9. Cunningham, M. W. (2000). Pathogenesis of group A streptococcal infections. Clin Microbiol Rev 13, 470-511.
10. Dieleman, L. A., Hoentjen, F., Qian, B. F., Sprengers, D., Tjwa, E., Torres, M. F., Torrice, C. D., Sartor, R. B. & Tonkonogy, S. L. (2004). Reduced ratio of protective versus proinflammatory cytokine responses to commensal bacteria in HLA-B27 transgenic rats. Clin Exp Immunol 136, 30-39.
11. Egesten, A., Eliasson, M., Johansson, H. M., Olin, A. I., Mörgelin, M., Müeller, A., Pease, J. E., Frick, I. M. & BjörcK L. (2007). The CXC chemokine MIG/CXCL9 is important in innate immunity against Streptococcus pyogenes. J Infect Dis 195, 684-693.
12. Eliasson, M., Frick, I. M., Collin, M., Sorensen, O. E., Bjorck, L. & Egesten, A. (2007). M1 protein of Streptococcus pyogenes increases production of the antibacterial CXC chemokine MIG/CXCL9 in pharyngeal epithelial cells. Microb Pathog Aug 1 [Epub ahead of print]
13. Fischetti, V. A. (1989). Streptococcal M protein: molecular design and biological behavior. Clin Microbiol Rev 2, 285-314.
14. Goebeler, M., Toksoy, A., Spandau, U., Engelhardt, E., Brocker, E. B. & Gillitzer, R. (1998). The C-X-C chemokine Mig is highly expressed in the papillae of psoriatic lesions. J Pathol 184, 89-95.
15. Goldman, M. J., Anderson, G. M., Stolzenberg, E. D., Kari, U. P., Zasloff, M. & Wilson, J. M. (1997). Human beta-defensin-1 is a salt-sensitive antibiotic in lung that is inactivated in cystic fibrosis. Cell 88, 553-560.
16. Granucci, F. & Ricciardi-Castagnoli, P. (2003). Interactions of bacterial pathogens with dendritic cells during invasion of mucosal surfaces. Curr Opin Microbiol 6, 72-76.
17. Hashikawa, S., Iinuma, Y., Furushita, M., Ohkura, T., Nada, T., Torii, K., Hasegawa, T. & Ohta, M. (2004). Characterization of group C and G streptococcal strains that cause streptococcal toxic shock syndrome. J Clin Microbiol 42, 186-192.
18. Herwald, H., Cramer, H., Mörgelin, M., Russell, W., Sollenberg, U., Norrby-Teglund, A., Flodgaard, H., Lindbom, L. & Björck, L. (2004). M protein, a classical bacterial virulence determinant, forms complexes with fibrinogen that induce vascular leakage. Cell 116, 367-379.
19. Heumann, D., Barras, C., Severin, A., Glauser, M. P. & Tomasz, A. (1994). Gram-positive cell walls stimulate synthesis of tumor necrosis factor alpha and interleukin-6 by human monocytes. Infect Immun 62, 2715-2721.
20. Honore, P. M., Lozana, A., Defalque, D. & Estratiou, A. (1996). Fatal septic shock due to Lancefield group G streptococci. Acta Clin Belg 51, 57-60.
21. Johansson, H. M., Mörgelin, M. & Frick, I. M. (2004). Protein FOG - a streptococcal inhibitor of neutrophil function. Microbiology 150, 4211-4221.
22. Lewthwaite, P., Parsons, H. K., Bates, C. J., McKendrick, M. W. & Dockrell, D. H. (2002). Group G streptococcal bacteraemia: an opportunistic infection associated with immune senescence. Scand J Infect Dis 34, 83-87.
23. Liao, F., Rabin, R. L., Yannelli, J. R., Koniaris, L. G., Vanguri, P. & Farber, J. M. (1995). Human MIG chemokine: biochemical and functional characterization. J Exp Med 182, 1301-1314.
24. Miörner, H., Johansson, G. & Kronvall, G. (1983). Lipoteichoic acid is the major cell wall component responsible for surface hydrophobicity of group A streptococci. Infect Immun 39, 336-343.
25. Müller-Alouf, H., Alouf, J. E., Gerlach, D., Ozegowski, J. H., Fitting, C. & Cavaillon, J. M. (1994). Comparative study of cytokine release by human peripheral blood mononuclear cells stimulated with Streptococcus pyogenes superantigenic erythrogenic toxins, heat-killed streptococci, and lipopolysaccharide. Infect Immun 62, 4915-4921.
26. Navarre, W. W. & Schneewind, O. (1999). Surface proteins of gram-positive bacteria and mechanisms of their targeting to the cell wall envelope. Microbiol Mol Biol Rev 63, 174-229.
27. Nitsche, D. P., Johansson, H. M., Frick, I. M. & Mörgelin, M. (2006). Streptococcal protein FOG, a novel matrix adhesin interacting with collagen I in vivo. J Biol Chem 281, 1670-1679.
28. Nitsche-Schmitz, D. P., Johansson, H., Sastalla, I., Reissmann, S., Frick, I. M. & Chhatwal, G. S. (2007). Group G streptococcal IgG binding molecules FOG and protein G have different impact on opsonization by C1q. J Biol Chem 282, 17530-17536.
29. Norrby-Teglund, A., Chatellier, S., Low, D. E., McGeer, A., Green, K. & Kotb, M. (2000). Host variation in cytokine responses to superantigens determine the severity of invasive group A streptococcal infection. Eur J Immunol 30, 3247-3255.
30. Oster, H. R. & Bisno, A. L. (2000). Group C and G Streptococcal Infections: Epidemiologic and Clinical Aspects. Washington, DC: American Society for Microbiology.
31. Rodrigues, M. E., Melo, M. C., Reis, F. J. & Penna, F. J. (1994). Concentration of electrolytes in the sweat of malnourished children. Arch Dis Child 71, 141-143.
32. Schmid, J., Hunter, P. R., White, G. C., Nand, A. K. & Cannon, R. D. (1995). Physiological traits associated with success of Candida albicans strains as commensal colonizers and pathogens. J Clin Microbiol 33, 2920-2926.
33. Simpson, W. J., Robbins, J. C. & Cleary, P. P. (1987). Evidence for group A-related M protein genes in human but not animal-associated group G streptococcal pathogens. Microb Pathog 3, 339-350.
34. Sylvetsky, N., Raveh, D., Schlesinger, Y., Rudensky, B. & Yinnon, A. M. (2002). Bacteremia due to beta-hemolytic Streptococcus group G: increasing incidence and clinical characteristics of patients. Am J Med 112, 622-626.
35. van der Merwe, D. E., Ubbink, J. B., Delport R., Becker, P., Dhatt, G. S. & Vermaak, W. J. (2002). Biological variation in sweat sodium chloride conductivity. Ann Clin Biochem 39, 39-43.
36. Vartian, C., Lerner, P. I., Shlaes, D. M. & Gopalakrishna, K. V. (1985). Infections due to Lancefield group G streptococci. Medicine (Baltimore) 64, 75-88.
37. Veckman, V., Miettinen, M., Matikainen, S., Lande, R., Giacomini, E., Coccia, E. M. & Julkunen, I. (2003). Lactobacilli and streptococci induce inflammatory chemokine production in human macrophages that stimulates Th1 cell chemotaxis. J Leukoc Biol 74, 395-402.
38. Whicher, J. T. & Evans, S. W. (1990). Cytokines in disease. Clin Chem 36, 1269-1281.
39. Yang, D., Chen, O., Hoover, D. M., Staley, P., Tucker, K. D., Lubkowski, J. & Oppenheim, J. J. (2003). Many chemokines including CCL20/MIP-3alpha display antimicrobial activity. J Leukoc Biol 74, 448-455.